Lung Cancer

Data indicates that RITA's RF technology effective in treating lung tumors

Published in Cancer Weekly, May 14th, 2002

RITA Medical Systems, Inc., (RITA) has announced that the results of a clinical study on the use of its proprietary radiofrequency (RF) ablation technology show the minimally invasive treatment appears to be effective in treating cancerous lung tumors when surgery is not an option, which is the case for the majority of lung cancer patients.

Data from the study, which was conducted at UCLA, St. George Hospital in Sydney, Australia, and Pisa University Hospital in Pisa, Italy, were presented at the European Congress of Radiology, held in Vienna, Austria in March 2002, by Riccardo Lencioni, MD, professor of diagnostic and interventional radiology at the University of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2002-05-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry